Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests

Gynecologic Oncology

Volumn 122, Issue 2, 2011, Pages 307-312

  Sznurkowski, Jacek J ^a   Zawrocki, Anton ^a   Emerich, Janusz ^a   Sznurkowska, Katarzyna ^a   Biernat, Wojciech ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

IDO, FOXP3; Immune escape; Prognosis; Vulvar SCC

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; TRANSCRIPTION FACTOR FOXP3;

AGE; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SQUAMOUS CELL CARCINOMA; VULVA CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MIDDLE AGED; MULTIVARIATE ANALYSIS; T-LYMPHOCYTES, REGULATORY; VULVAR NEOPLASMS;

EID: 79960455843     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.04.050     Document Type: Article

References (46)

1. S.R. Sturgeon, L.A. Bronton, S.S. Devesa, and R.J. Kurman In situ and invasive vulvar cancer incidence trends (1973 to 1987) Am J Obstet Gynecol 166 1992 1482 1485
2. A.C. Ansink, and A.P. Heintz Epidemiology and etiology of squamous cell carcinoma of the vulva Eur J Obstet Gynecol Reprod Biol 48 1993 111 115 (Pubitemid 23108941)
3. J. Coulter, and N. Gleeson Local and regional recurrence of vulval cancer: management dilemmas Best Pract Res Clin Obstet Gynaecol 17 2003 663 681 (Pubitemid 37168286)
4. J.M. Monaghan The management of carcinoma of the vulva J.H. Shepherd, J.M. Monaghan, Clinical gynaecological oncology 2nd ed. 1990 Blackwell Scientific Publications Oxford 140 167
5. U. Beller, M.A. Quinn, J.L. Benedet, W.T. Creasman, H.Y. Ngan, and P. Maisonneuve Carcinoma of the vulva Int J Gynaecol Obstet 95 2006 S7 S27
6. T. Maggino, F. Landoni, E. Sartori, P. Zola, A. Gadducci, and C. Alessi Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study Cancer 89 2000 116 122 (Pubitemid 30451281)
7. A. Gadducci, L. Cionini, A. Romanini, A. Fanucchi, and A.R. Genazzani Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer Crit Rev Oncol Hematol 60 2006 227 241 (Pubitemid 44709620)
8. S.A. Rosenberg Prognosis in human tumor immunology and immunotherapy Nature 411 2001 380 384 (Pubitemid 32467048)
9. M. Gerloni, and M. Zanetti CD4 T cells in tumor immunity Springer Semin Immunopathol 27 2005 37 48 (Pubitemid 40905061)
10. C. Uyttenhove, L. Pilotte, I. Theate, V. Stroobant, D. Colau, and N. Parmentier Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nat Med 9 2003 1269 1274 (Pubitemid 37279849)
11. M. Friberg, R. Jennings, M. Alsarraj, S. Dessureault, A. Cantor, and M. Extermann Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection Int J Cancer 101 2002 151 155 (Pubitemid 34970907)
12. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, and A.L. Mellor Inhibition of T cell proliferation by macrophage tryptofan catabolism J Exp Med 189 1999 1363 1372 (Pubitemid 29227522)
13. G. Frumento, R. Rotondo, M. Tonetti, G. Damonte, U. Benatti, and G.B. Ferrera Tryptofan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase J Exp Med 196 2002 459 468
14. S. Sakaguchi, N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, and M. Itoh Immunologic tolerance maintained by CD25+CD4+ regulatory T cells their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol Rev 182 2001 18 32 (Pubitemid 33070205)
15. H.Y. Wang, D.A. Lee, G. Peng, Z. Guo, Y. Li, and Y. Kiniwa Tumor specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy Immunity 20 2004 107 118 (Pubitemid 38134298)
16. D. Wolf, A.M. Wolf, H. Rumpold, H. Fiegl, A.G. Zeimet, and E. Muller-Holzner The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer Clin Cancer Res 11 2005 8326 8331 (Pubitemid 41746944)
17. E.Y. Woo, C.S. Chu, T.J. Goltez, K. Schlienger, H. Yeh, and G. Coukos Regulatory CD4+CD25+ T cells in tumors from patients with early stage non small cell lung cancer and late-stage ovarian cancer Cancer Res 61 2001 4766 4772 (Pubitemid 32691889)
18. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, and P. Mottram Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 2004 942 949 (Pubitemid 39273735)
19. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, and P. Mottram Modulation of tryptophan catabolism by human leukemic cells results in conversion of CD25- into CD25+ T regulatory cells Blood 109 2007 2871 2877
20. A.L. Mellor, B. Baban, P. Chandler, B. Marshall, K. Jhaver, and A. Hansen Cutting edge: induced indoleamine 2,3-dioxygenase expression in dendritic cell subsets suppress T cell clonal expansion J Immunol 171 2003 1652 1655 (Pubitemid 36966447)
21. S. Hori, T. Noura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057 1064
22. J.H. Shepherd Cervical and vulva cancer: changes in FIGO definitions of staging Br J Obstet Gynaecol 103 1996 405 406 (Pubitemid 26141629)
23. S. Pecorelli FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 2009 103 104
24. K. Ino, E. Yamamoto, K. Shibata, H. Kajiyama, N. Yoshida, and M. Terauchi Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival Clin Cancer Res 14 8 2008 2310 2317 (Pubitemid 351551062)
25. T. Inaba, K. Ino, H. Kajiyama, K. Shibata, E. Yamamoto, and S. Kondo Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy Gynecol Oncol 117 2010 423 428
26. W. Shah, X. Yan, L. Jing, Y. Zhou, H. Chen, and Y. Wang A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix Cell Mol Immunol 8 2010 59 66
27. N. Yoshida, H. Abe, T. Ohkuri, D. Wakita, M. Sato, and D. Noguchi Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance Int J Oncol 28 2006 1089 1098
28. O. Wakabayashi, K. Yamazaki, S. Oizumi, F. Hommura, I. Kinoshita, and S. Ogura CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell cancers Cancer Sci 94 2003 1003 1009 (Pubitemid 37521216)
29. A.S. Mansfield, P.S. Heikkila, A.T. Vaara, K.A. von Smitten, J.M. Vakkila, and M.H. Leidenius Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer BMC Cancer 9 Jul 15 2009 231
30. Q. Gao, S.J. Qiu, J. Fan, J. Zhou, X.Y. Wang, and Y.S. Xiao Intratumoral balance of regulatory and cytotoxicT cells is associated with prognosis of hepatocellular carcinoma after resection J Clin Oncol 25 2007 2586 2593 (Pubitemid 47041232)
31. C. Loddenkemper, M. Schernus, M. Noutsis, H. Stein, E. Thiel, and D. Nagorsen In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer J Transl Med 4 2006 52
32. T. Nakamura, T. Shima, A. Saeki, T. Hidaka, A. Nakashima, and O. Takikawa Expression of indoleamine 2, 3-dioxygenase and recruitment of FOXP3-expressing regulatory T cells in the development and progression of uterine cervical cancer Cancer Sci 98 6 2007 874 881 (Pubitemid 46691826)
33. H. Suzuki, N. Chikazawa, T. Tasaka, J. Wada, A. Yamasaki, and Y. Kitaura Intratumoral CD8+ T/FOXP3+ cells ratio is a predictive marker for survival in patients with colorectal cancer Nat Rev Clin Oncol 7 6 2010 299
34. A.N. Akbar, M. Vukmanovic-Stejic, L.S. Taams, and D.C. Macallan The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery Nat Rev Immunol 7 2007 231 237
35. + regulatory T cells are derived by rapid turnover of memory populations in vivo J Clin Invest 116 2006 2423 2433 (Pubitemid 44330141)
36. W. Chen, W. Jin, N. Hardegen, K.J. Lei, L. Li, and N. Marinos Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 12 2003 1875 1886 (Pubitemid 38032120)
37. M.S. Sundrud, and A. Rao New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT Curr Opin Immunol 19 2007 287 293 (Pubitemid 46687019)
38. J. Fu, D. Xu, Z. Liu, M. Shi, P. Zhao, and B. Fu Increased regulatory T cells correlate with CD8 T cell impairment and poor survival in hepatocellular carcinoma patients Gastroenterology 132 2007 2328 2339 (Pubitemid 46890865)
39. K.L. Ling, S.E. Pratap, G.J. Bates, B. Singh, N.J. Mortensen, and B.D. George Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients Cancer Immun 7 2007 7
40. T. Sasada, M. Kimura, Y. Yoshida, M. Kanai, and A. Takabayashi CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression Cancer 98 2003 1089 1099 (Pubitemid 37022112)
41. G.J. Bates, S.B. Fox, C. Han, R.D. Leek, J.F. Garcia, and A.L. Harris Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse J Clin Oncol 24 2006 5373 5380 (Pubitemid 46623168)
42. N. Hiraoka, K. Onozato, T. Kosuge, and S. Hirohashi Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions Clin Cancer Res 12 2006 5423 5434 (Pubitemid 44497257)
43. G.G. Grabenbauer, G. Lahmer, L. Distel, and G. Niedobitek Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma Clin Cancer Res 12 2006 3355 3360
44. E. Sato, S.H. Olson, J. Ahn, B. Bundy, H. Nishikawa, and F. Qian Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci U S A 102 2005 18538 18543 (Pubitemid 43011261)
45. A.J. Muller, J.B. DuHadaway, P.S. Donover, E. Sutanto-Ward, and G.C. Prendergast Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy Nat Med 11 2005 312 319 (Pubitemid 40460560)
46. D.H. Munn, and A.L. Mellor Indoleamine 2,3-dioxygenase and tumor induced tolerance J Clin Invest 117 2007 1147 1154 (Pubitemid 46718399)